- Home
- KLRS vs BMR Comparison
KLRS vs BMR Comparison
Compare KLRS & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLRS | BMR |
|---|---|---|
| Founded | 2019 | 2009 |
| Country | United States | Israel |
| Employees | N/A | 21 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 30.1M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | KLRS | BMR |
|---|---|---|
| Price | $8.40 | $1.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $20.67 | N/A |
| AVG Volume (30 Days) | ★ 170.2K | 122.4K |
| Earning Date | 02-24-2026 | 08-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,131,000.00 |
| Revenue This Year | N/A | $21.21 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.96 |
| 52 Week Low | $2.14 | $1.54 |
| 52 Week High | $12.90 | $4.87 |
Technical Indicators
Market Signals| Indicator | KLRS | BMR |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 47.64 |
| Support Level | $7.92 | $1.54 |
| Resistance Level | $9.09 | $2.03 |
| Average True Range (ATR) | 0.94 | 0.13 |
| MACD | -0.22 | 0.01 |
| Stochastic Oscillator | 10.47 | 75.00 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.